期刊文献+

血清降钙素原在慢性阻塞性肺疾病急性加重期抗菌治疗中的指导作用 被引量:37

The guiding role of serum procaicitonin in antibiotic therapy for acute exacerbation of chronic obstructivepulmonary disease
原文传递
导出
摘要 目的探讨降钙素原(PCT)在慢性阻塞性肺疾病急性加重期(AECOPD)抗生素治疗中的指导作用。方法入选72例AECOPD患者,随机分成PCT组(40例)和常规治疗组(32例)。PCT组患者根据血清PCT水平决定抗生素的使用和停用,如PCT〈0.25址g/L停用抗生素;常规治疗组患者由主治医师根据临床症状决定抗生素的使用。主要观察指标为抗生素的使用率、抗生素使用时间、住院天数、临床有效率、二重感染、加重以及死亡例数等。结果PCT组患者临床治疗有效率82.5%,与常规治疗组75.8%比较,差异元统计学意义(X^2=0。217,P=0.641),但是PCT组患者抗生素使用率47.5%,较常规治疗组71.9%明显降低(X^2=4.346,P=0.037),抗生素平均使用天数也更短[(6.8±3.3)d与(10.2±3.7)d,t=3.116,P=0.0033,PCT组患者住院天数(11.7士5.2)d较常规治疗组患者(20.3±8.7)d更短(t=5.202,P=0.000)。两组的二重感染的发生率(2.5%与18.8%,X^2=3.657,P=0.056)、加重例数(3例与4例,X^2=0.097,P=0.756)、死亡率(2.5%与6.3%,7。=0.039,P=0.843)差异无统计学意义。结论PCT可能是指导AECOPD抗生素使用的=项较合适的指标,能有效降低抗生素的不合理使用,降低二重感染,减少住院时间。 Objective To explore the guiding role of serum procalcitonin (PCT) in antibiotic therapy during acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods Totally 72 patients with AECOPD were randomly divided into PCT group (n=40) and conventional therapy group(n=32). For patients in PCT group, the use of antibiotics was based on PCT serum levels,antibiotics were stopped when PCT〈0.25 /%g/L, while in conventional treatment group, the use of antibiotics was based on clinical symptoms of patients. The main observation indexes included ratio of antibiotic usage, time of antibiotics use, hospital stay, clinical efficacy, aggravating eases and death cases. Results There were no significant difference in clinical efficacy between the two groups(82.5 % vs. 75.8%, )X^2 = 0. 217, P = 0. 641), however, the ratio of antibiotics usage in PCT patients was significantly lower than conventional therapy group (47.5 % vs. 71.9 %, Z% = 4. 346, P= 0. 037), average time of antibiotics use and days of hospital stay were shorter in PCT treatment group than conventional therapy group %(6.84%3.27) d vs. (10.22±3.67)d, Zz =3. 116, P=0. 003; (11.7 ±5.2) d vs. (20.3+8.7) d,X^2=5.5202, P=0. 0003. There were no difference in double infection incidence (2.50%vs. 18.8%, X^2 = 3. 657, P= 0. 056), aggravating cases (3 cases vs. 4 cases, X^2 = 0. 097, P=0. 756) and mortality (2.5% vs. 6.3%, Z2 =0. 039, P=0. 843) between the two groups. Conclusions Serum PCT level may be an appropriate indicator to guide antibiotic therapy in patients with AECOPD in view of its effective decreases of excessive use of antibiotics, double infection opportunities and hospitalization time.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第5期396-398,共3页 Chinese Journal of Geriatrics
关键词 降钙素 肺疾病 慢性阻塞性 抗菌药 Calcitonin Pulmonary disease, chronic obstructive Anti-bacterial agents
作者简介 通信作者:丁海波,Email:dindoct@163.com
  • 相关文献

参考文献8

  • 1Roca B, Almagro P, L6pez F, et al. Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in general medicine departments. Intern Emerg Med, 2011, 6..47-54.
  • 2Rothberg MB, Pekow PS, Lahti M. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA, 2010, 303 : 2035-2042.
  • 3中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007修订版).中华结核和呼吸杂志,2007,30:817-817.
  • 4Anthonisen NR, Manfreda J, Warren Antibiotic therapy in exacerbation obstructive pulmonary disease . Ann CP, et al. of chronic Intern Med, 1987, 106:196-204.
  • 5Christ-Crain M, Mailer B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J,2007,30:556-573.
  • 6吴亮,严静,谭成戊,龚仕金,戴海文,陈进,蔡国龙,虞意华.降钙素原测定指导老年人呼吸机相关性肺炎抗生素治疗的使用价值[J].中华老年医学杂志,2010,29(9):705-708. 被引量:26
  • 7Stolz D, Christ Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD.. a randomized, controlled trial comparing procalcitonin- guidance with standard therapy. Chest, 2007, 131 .. 9-19.
  • 8Schuetz P, Christ-erain M,Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA,2009,302 : 1059-1066.

二级参考文献12

  • 1姜辉,俞森洋.临床肺感染评分诊断通气机相关肺炎[J].中华医院感染学杂志,2005,15(7):751-752. 被引量:37
  • 2Zeni F,Freeman BD,Natanson C,et al.Antiinflamatory therapies to treat sepsis and septic shock.Crit Care Med,1997,25:1095-1100.
  • 3Luna CM,Blanzaco D,Niederman MS,et al.Resolution of ventilator-associated pneumonia:prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.Crit Care Med,2003,31:676-682.
  • 4Tejerina E,Frutos-Vivar F,Restrepo MI,et al.Incidence,risk factors,and outcome of ventilatorassociated pneumonia.J Crit Care,2006,21:56-65.
  • 5Christ-Crain M,Jaccard-Stolz D,Bingisser R,et al.Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:cluster-randomised,single-blinded intervention trial.Lancet,2004,363:600-607.
  • 6Christ-Crain M,Stolz D,Bingisser R,et al.Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia:a randomized trial.Am J Respir Crit Care Med,2006,174:84-93.
  • 7Stolz D,Christ-Crain M,Bingisser R,et al.Antibiotic treatment of exacerbations of COPD:a randomized,controlled trial comparing procalcitoninguidance with standard therapy.Chest,2007,131:9-19.
  • 8Briel M,Christ-Crain M,Young J,et al.Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care:study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners[ISRCTN73182671].BMC Fam Pract,2005,6:34.
  • 9Lee CC,Chen SY,Tsai CL,et al.Prognostic value of mortality in emergency department sepsis score,procalcitonin,and C-reactive protein in patients with sepsis at the emergency department.Shock,2008,29:322-327.
  • 10Soo Hoo GW,Wen YE,Ngugen TV,et al.Impact of guidelines in the management of severe hospitalacquired pneumonia.Chest,2005,128:2778-2787.

共引文献75

同被引文献276

引证文献37

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部